{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:25:36Z","timestamp":1793996736228,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU22-04-00526"],"award-info":[{"award-number":["NU22-04-00526"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["00023752"],"award-info":[{"award-number":["00023752"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.pnpbp.2023.110819","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:53:07Z","timestamp":1687812787000},"page":"110819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D2\/5-HT receptor activity"],"prefix":"10.1016","volume":"127","author":[{"given":"Iveta","family":"Vojtechova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Tuckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radomir","family":"Juza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Stuchlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Kelemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Petrasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pnpbp.2023.110819_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1369-1600.2010.00223.x","article-title":"Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole","volume":"16","author":"B\u00e4ckstr\u00f6m","year":"2011","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.pnpbp.2023.110819_bb0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0091-3057(00)00409-3","article-title":"Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats","volume":"67","author":"Bast","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110819_bb0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pbb.2005.01.012","article-title":"The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating","volume":"80","author":"Buben\u00edkov\u00e1","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110819_bb0020","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","article-title":"Models of schizophrenia in humans and animals based on inhibition of NMDA receptors","volume":"32","author":"Buben\u00edkov\u00e1-Vale\u0161ov\u00e1","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8\u20139","key":"10.1016\/j.pnpbp.2023.110819_bb0025","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/FBP.0000000000000178","article-title":"MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol","volume":"26","author":"Deiana","year":"2015","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110819_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0091-3057(02)00794-3","article-title":"Early maternal deprivation and prepulse inhibition: the role of the postdeprivation environment","volume":"73","author":"Ellenbroek","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0035","article-title":"Can 5-HT3 antagonists contribute toward the treatment of schizophrenia?","volume":"26","author":"Ellenbroek","year":"2014","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110819_bb0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-006-0658-y","article-title":"The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice","volume":"191","author":"Fejgin","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2023.110819_bb0045","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/2041-210X.12584","article-title":"BORIS: a free, versatile open-source event-logging software for video\/audio coding and live observations","volume":"7","author":"Friard","year":"2016","journal-title":"Methods Ecol. Evol."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110819_bb0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2011.03.053","article-title":"Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia","volume":"222","author":"Gururajan","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110819_bb0055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.pharep.2019.04.007","article-title":"Co-treatment with antidepressants and aripiprazole reversed the MK-801-induced some negative symptoms of schizophrenia in rats","volume":"71","author":"Hereta","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112769","article-title":"Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex","volume":"393","author":"Hereta","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"10202","key":"10.1016\/j.pnpbp.2023.110819_bb0065","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110819_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2010.01.010","article-title":"Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway","volume":"471","author":"Ishii","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0075","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/med.21666","article-title":"Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders","volume":"40","author":"Juza","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"9","key":"10.1016\/j.pnpbp.2023.110819_bb0080","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/biom11091262","article-title":"Synthesis and in vitro evaluation of novel dopamine receptor D2 3, 4-dihydroquinolin-2 (1H)-one derivatives related to aripiprazole","volume":"11","author":"Juza","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.pnpbp.2023.110819_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114193","article-title":"Novel D2\/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment","volume":"232","author":"Juza","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110819_bb0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1461145703003651","article-title":"Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia","volume":"6","author":"Kasper","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110819_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbr.2013.03.006","article-title":"Two learning tasks provide evidence for disrupted behavioural flexibility in an animal model of schizophrenia-like behaviour induced by acute MK-801: a dose\u2013response study","volume":"246","author":"Lobellova","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110819_bb0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1461145709991143","article-title":"Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania","volume":"13","author":"Mavrikaki","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0110","first-page":"64","article-title":"Role of serotonin in the action of atypical antipsychotic drugs","volume":"3","author":"Meltzer","year":"1995","journal-title":"Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110819_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2007.10.010","article-title":"Effects of aripiprazole\/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats","volume":"54","author":"Nordquist","year":"2008","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2023.110819_bb0120","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00213-021-05788-w","article-title":"Long acting aripiprazole influences cognitive functions in recent onset schizophrenia","volume":"238","author":"Peitl","year":"2021","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2023.110819_bb0125","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1176\/appi.ajp.159.8.1375","article-title":"Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission","volume":"159","author":"Perry","year":"2002","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fnagi.2018.00250","article-title":"The McGill transgenic rat model of Alzheimer\u2019s disease displays cognitive and motor impairments, changes in anxiety and social behavior, and altered circadian activity","volume":"10","author":"Petrasek","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110819_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11689-021-09357-2","article-title":"mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus","volume":"13","author":"Petrasek","year":"2021","journal-title":"J. Neurodev. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110819_bb0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00213-011-2200-0","article-title":"Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia","volume":"216","author":"Profaci","year":"2011","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2023.110819_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1358\/mf.2010.32.2.1481727","article-title":"The effect of the NMDA receptor antagonist dizocilpine on behavioral manifestations of serotonin and adrenergic antidepressants in rats","volume":"32","author":"Pruus","year":"2010","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2023.110819_bb0150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.pnpbp.2005.03.004","article-title":"(+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia","volume":"29","author":"Rung","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110819_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008877-199501000-00009","article-title":"Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats","volume":"6","author":"Sams-Dodd","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110309","article-title":"Different neurocognitive profiles of risperidone and aripiprazole in the FIRST episode of psychosis: a 3-year follow-up comparison","volume":"110","author":"Seti\u00e9n-Suero","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2023.110819_bb0165","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2023.110819_bb0170","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.clinthera.2010.01.021","article-title":"Aripiprazole in schizophrenia and schizoaffective disorder: a review","volume":"32","author":"Stip","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2023.110819_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5507\/crj.2015.001","article-title":"Animal models of schizophrenia with a focus on models targeting NMDA receptors","volume":"1","author":"Svojanovsk\u00e1","year":"2015","journal-title":"Cognit. Remediat. J."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110819_bb0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1037\/bne0000066","article-title":"Attenuation of MK-801-induced behavioral perseveration by typical and atypical antipsychotic pretreatment in rats","volume":"129","author":"Tuplin","year":"2015","journal-title":"Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2023.110819_bb0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neures.2006.04.007","article-title":"Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between long-Evans and Wistar rats","volume":"55","author":"Vales","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2023.110819_bb0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbr.2016.03.020","article-title":"Dizocilpine (MK-801) impairs learning in the active place avoidance task but has no effect on the performance during task\/context alternation","volume":"305","author":"Vojtechova","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2023.110819_bb0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0706743718773728","article-title":"An overview of animal models related to schizophrenia","volume":"64","author":"Winship","year":"2019","journal-title":"Can. J. Psychiatr."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584623001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584623001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:55:34Z","timestamp":1793994934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584623001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":40,"alternative-id":["S0278584623001057"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110819","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D2\/5-HT receptor activity","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110819"}}